Has Elizabeth Grieshaber, MD received payments from drug or device companies?

Yes. Drug and device makers reported $156,497 in general payments to Elizabeth Grieshaber, MD across 1,286 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Elizabeth Grieshaber, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Elizabeth Grieshaber, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Elizabeth Grieshaber, MD

Dermatology · Metairie, LANPI 1437390424

Payments from drug & device makers

$156,497in general payments, 2019–2025

Across 1,286 payments — averaging $121.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Galderma Laboratories, L.p.$136K
AbbVie$3K
Johnson & Johnson$3K
Lumenis, Inc$2K
Novartis$1K
Sun Pharmaceutical Industries Inc.$1K
plus $10K from 36 others

What the payments were for

Consulting fees$6,9004%
Speaking & faculty fees$117,15875%
Travel & lodging$4,8023%
Food & beverage$26,94417%
Education$6930%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Galderma Laboratories, L.p.	222	$135,659
AbbVie(2 entities)	237	$3,113
Johnson & Johnson	58	$2,768
Lumenis, Inc	2	$2,138
Novartis	78	$1,427
Sun Pharmaceutical Industries Inc.	60	$1,280
Mayne Pharma Commercial LLC	127	$1,172
Sanofi	80	$1,058
E.r. Squibb & Sons, L.L.C.	40	$1,004
Regeneron Healthcare Solutions, Inc.	49	$893
Pfizer	54	$814
UCB, Inc.	35	$692
LEO Pharma Inc.	49	$621
Amgen	23	$454
Incyte Corporation	20	$443
Lilly USA, LLC	24	$428
Dermavant Sciences, Inc.	22	$293
Almirall LLC	13	$279
Arcutis Biotherapeutics, Inc.	16	$268
Sanofi-aventis U.S. LLC	2	$198
Revance Therapeutics, Inc.	4	$186
Journey Medical Corporation	9	$178
VYNE Pharmaceuticals Inc.	6	$149
Ortho Dermatologics, A Division Of Bausch Health US, LLC	9	$131
Organon	9	$129
Biofrontera Inc.	9	$129
Genentech USA, Inc.	6	$116
Botanix SB Inc	3	$63
Dermira, Inc.	3	$61
Mallinckrodt Hospital Products Inc.	2	$49
Promius Pharma LLC	2	$44
Medimetriks Pharmaceuticals, Inc.	2	$36
Biotronik NRO, Inc.	1	$35
Cipher Pharmaceuticals US LLC	1	$33
Mission Pharmacal Company	2	$26
Boehringer Ingelheim	1	$25
Bristol Myers Squibb	1	$23
Prugen, Inc. Pharmaceuticals	1	$18
Verrica Pharmaceuticals Inc.	1	$17
Merz North America, Inc.	1	$16
Helsinn Therapeutics (U.S.), Inc.	1	$16
Encore Dermatology Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AKLIEF$52,291
ORACEA$15,867
TWYNEO$13,500
EPSOLAY$10,500
EPIDUO FORTE$7,155
Tremfya$1,781
Sotyktu$390
DAXXIFY$140
Skyrizi$124
COSENTYX$114

How this compares

$156,497 in reported general payments places this provider in the 85th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$108,779

Medicare patients

379

Services billed

2,635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	18	$67,884
Doxycycline Hyclate	117	$6,012
Clobetasol Propionate	80	$3,318
Fluocinonide	48	$1,638
Ketoconazole	91	$1,566
Tretinoin	14	$1,538
Hydroxychloroquine Sulfate	32	$1,383
Triamcinolone Acetonide	150	$1,283
Fluorouracil	18	$1,024
Azelaic Acid	14	$955
ValacyclovirValacyclovir Hcl	37	$844
Betamethasone Dipropionate	19	$739
Minoxidil	45	$469
Calcipotriene	12	$463
Spironolactone	23	$430

Paid to pharmacies, not to this prescriber.

Other dermatology in Metairie

Robert KoppelMetairie$878K
Katherine HolcombMetairie$696K
Rachael Delahoussaye-ShieldsMetairie$83K
Michelle GerdesMetairie$20K
Diane RoseMetairie$9K
Jordan WhatleyBaton Rouge$27.9M
Ira ThorlaBaton Rouge$5.6M
Deirdre HooperNew Orleans$3.2M
Sarah JacksonNew Orleans$1.7M
Kyle ColemanThibodaux$1.5M

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →